These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37023856)

  • 1. N-nitrosamine Mitigation with Nitrite Scavengers in Oral Pharmaceutical Drug Products.
    Bayne AV; Misic Z; Stemmler RT; Wittner M; Frerichs M; Bird JK; Besheer A
    J Pharm Sci; 2023 Jul; 112(7):1794-1800. PubMed ID: 37023856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bumetanide as a Model NDSRI Substrate: N-nitrosobumetanide Impurity Formation and its Inhibition in Bumetanide Tablets.
    Shakleya D; Asmelash B; Alayoubi A; Abrigo N; Mohammad A; Wang J; Zhang J; Yang J; Marzan TA; Li D; Shaklah M; Alsharif FM; Desai S; Faustino PJ; Ashraf M; O'Connor T; Vera M; Raw A; Sayeed VA; Keire D
    J Pharm Sci; 2023 Dec; 112(12):3075-3087. PubMed ID: 37364772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of N-Nitrosamine Formation in Drug Products: A Model Study.
    Nanda KK; Tignor S; Clancy J; Marota MJ; Allain LR; D'Addio SM
    J Pharm Sci; 2021 Dec; 110(12):3773-3775. PubMed ID: 34400183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Nitrite Excipient Database: A Useful Tool to Support N-Nitrosamine Risk Assessments for Drug Products.
    Boetzel R; Schlingemann J; Hickert S; Korn C; Kocks G; Luck B; Blom G; Harrison M; François M; Allain L; Wu Y; Bousraf Y
    J Pharm Sci; 2023 Jun; 112(6):1615-1624. PubMed ID: 35500671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Nitrosamine Formation in Pharmaceutical Solid Drug Products: Experimental Observations.
    Moser J; Ashworth IW; Harris L; Hillier MC; Nanda KK; Scrivens G
    J Pharm Sci; 2023 May; 112(5):1255-1267. PubMed ID: 36736774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling the Impact of Excipients Selection on Nitrosamine Formation towards Risk Mitigation.
    Berardi A; Jaspers M; Dickhoff BHJ
    Pharmaceutics; 2023 Jul; 15(8):. PubMed ID: 37631229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on nitrosamine formation by the interaction between drugs and nitrite. I. Measurement of the amount of nitrosamine formed in rat and guinea pig stomachs.
    Kawanishi T; Ohno Y; Takahashi A; Ishiwata H; Tanimura A; Kasuya Y; Omori Y
    J Toxicol Sci; 1981 Nov; 6(4):261-70. PubMed ID: 7338958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approaches to cancer prevention based on an understanding of N-nitrosamine carcinogenesis.
    Hecht SS
    Proc Soc Exp Biol Med; 1997 Nov; 216(2):181-91. PubMed ID: 9349687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive review of sources of nitrosamine contamination of pharmaceutical substances and products.
    Akkaraju H; Tatia R; Mane SS; Khade AB; Dengale SJ
    Regul Toxicol Pharmacol; 2023 Mar; 139():105355. PubMed ID: 36792049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of vitamin E as nitrite scavenger and N-nitrosamine inhibitor: a review.
    Lathia D; Blum A
    Int J Vitam Nutr Res; 1989; 59(4):430-8. PubMed ID: 2699323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the protective effect of ascorbic acid on nitrite- and nitrosamine-induced cytotoxicity and genotoxicity in human hepatoma line.
    Erkekoglu P; Baydar T
    Toxicol Mech Methods; 2010 Feb; 20(2):45-52. PubMed ID: 20100056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-tocopherol: uses in preventing nitrosamine formation.
    Mergens WJ; Kamm JJ; Newmark HL; Fiddler W; Pensabene J
    IARC Sci Publ (1971); 1978; (19):199-212. PubMed ID: 28277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitroso Impurities in Drug Products: An Overview of Risk Assessment, Regulatory Milieu, and Control Strategy.
    Charoo NA; Dharani S; Khan MA; Rahman Z
    AAPS PharmSciTech; 2023 Feb; 24(2):60. PubMed ID: 36759424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NDMA Formation Due to Active Ingredient Degradation and Nitrite Traces in Drug Product.
    Golob N; Peterlin S; Grahek R; Roškar R
    J Pharm Sci; 2023 May; 112(5):1277-1286. PubMed ID: 36925105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parts per billion of nitrite in microcrystalline cellulose by ion chromatography mass spectrometry with isotope labeled internal standard.
    Zhu K; Kerry M; Serr B; Mintert M
    J Pharm Biomed Anal; 2023 Oct; 235():115648. PubMed ID: 37611458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitrosated Active Pharmaceutical Ingredients - Lessons Learned?
    Holzgrabe U
    J Pharm Sci; 2023 May; 112(5):1210-1215. PubMed ID: 36720391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly sensitive two-dimensional ion chromatography mass spectrometry method for nitrite determination in hydroxypropyl methylcellulose.
    Zhu K; Kerry M; Serr B; Mintert M; Pursch M; Eeltink S; Desmet G
    J Pharm Biomed Anal; 2024 Sep; 248():116330. PubMed ID: 38981329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of plant polyphenols on the physicochemical properties, residual nitrites, and N-nitrosamine formation in dry-fried bacon.
    Deng S; Shi S; Xia X
    Meat Sci; 2022 Sep; 191():108872. PubMed ID: 35667189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on nitrosamine formation by the interaction between drugs and nitrite. II. Hepatotoxicity by the simultaneous administration of several drugs and nitrite.
    Kawanishi T; Ohno Y; Sunouchi M; Onoda K; Takahashi A; Kasuya Y; Omori Y
    J Toxicol Sci; 1981 Nov; 6(4):271-86. PubMed ID: 7338959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory Experiences with Root Causes and Risk Factors for Nitrosamine Impurities in Pharmaceuticals.
    Horne S; Vera MD; Nagavelli LR; Sayeed VA; Heckman L; Johnson D; Berger D; Yip YY; Krahn CL; Sizukusa LO; Rocha NFM; Bream RN; Ludwig J; Keire DA; Condran G
    J Pharm Sci; 2023 May; 112(5):1166-1182. PubMed ID: 36599405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.